Stephen Gordon Trans Medics Group, Inc. (TMDX) insider trading activity

Stephen Gordon is Chief Financial Officer of TransMedics Group, Inc.. Currently has a direct ownership of 21,299 shares of TMDX, which is worth approximately $1.62 Million. The most recent transaction as insider was on Feb 01, 2023, when has been sold 5,000 shares (Common Stock) at a price of $16.14 per share, resulting in proceeds of $80,700. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 21.3K

0% 3M change

62.9% 12M change

Total Value Held $1.62 Million

Stephen Gordon Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 01 2023	BUY Exercise of conversion of derivative security	$80,700 $16.14 p/Share	5,000 Added 31.82%	10,714 Common Stock
Jan 17 2023	SELL Open market or private sale	$300,600 $60.12 p/Share	5,000 Reduced 46.67%	5,714 Common Stock
Jan 17 2023	BUY Exercise of conversion of derivative security	$80,700 $16.14 p/Share	5,000 Added 31.82%	10,714 Common Stock
Dec 01 2022	SELL Open market or private sale	$617,300 $61.73 p/Share	10,000 Reduced 63.64%	5,714 Common Stock
Dec 01 2022	BUY Exercise of conversion of derivative security	$161,400 $16.14 p/Share	10,000 Added 38.89%	15,714 Common Stock
Nov 07 2022	SELL Open market or private sale	$567,200 $56.72 p/Share	10,000 Reduced 63.64%	5,714 Common Stock
Nov 07 2022	BUY Exercise of conversion of derivative security	$91,800 $9.18 p/Share	10,000 Added 38.89%	15,714 Common Stock
Oct 03 2022	SELL Open market or private sale	$417,400 $41.74 p/Share	10,000 Reduced 63.64%	5,714 Common Stock
Oct 03 2022	BUY Exercise of conversion of derivative security	$22,100 $2.21 p/Share	10,000 Added 38.89%	15,714 Common Stock
Sep 01 2022	SELL Open market or private sale	$509,300 $50.93 p/Share	10,000 Reduced 63.64%	5,714 Common Stock
Sep 01 2022	BUY Exercise of conversion of derivative security	$22,100 $2.21 p/Share	10,000 Added 38.89%	15,714 Common Stock
Aug 08 2022	SELL Open market or private sale	$480,900 $48.09 p/Share	10,000 Reduced 63.64%	5,714 Common Stock
Aug 08 2022	BUY Exercise of conversion of derivative security	$22,100 $2.21 p/Share	10,000 Added 38.89%	15,714 Common Stock
Jul 05 2022	SELL Open market or private sale	$350,000 $35.0 p/Share	10,000 Reduced 63.64%	5,714 Common Stock
Jul 05 2022	BUY Exercise of conversion of derivative security	$22,100 $2.21 p/Share	10,000 Added 38.89%	15,714 Common Stock
Sep 07 2021	SELL Open market or private sale	$350,000 $35.0 p/Share	10,000 Reduced 63.64%	5,714 Common Stock
Sep 07 2021	BUY Exercise of conversion of derivative security	$6,700 $0.67 p/Share	10,000 Added 38.89%	15,714 Common Stock
Jul 15 2021	SELL Open market or private sale	$350,000 $35.0 p/Share	10,000 Reduced 63.64%	5,714 Common Stock
Jul 15 2021	BUY Exercise of conversion of derivative security	$6,700 $0.67 p/Share	10,000 Added 38.89%	15,714 Common Stock
Jun 17 2021	SELL Open market or private sale	$300,000 $30.0 p/Share	10,000 Reduced 63.64%	5,714 Common Stock
Jun 17 2021	BUY Exercise of conversion of derivative security	$6,600 $0.66 p/Share	10,000 Added 50.0%	10,000 Common Stock
Jun 01 2021	BUY Exercise of conversion of derivative security	$3,828 $0.67 p/Share	5,714 Added 50.0%	5,714 Common Stock
Mar 15 2021	SELL Open market or private sale	$398,100 $39.81 p/Share	10,000 Reduced 100.0%	0 Common Stock
Mar 15 2021	BUY Exercise of conversion of derivative security	$6,700 $0.67 p/Share	10,000 Added 50.0%	10,000 Common Stock
Feb 16 2021	SELL Open market or private sale	$313,300 $31.33 p/Share	10,000 Reduced 100.0%	0 Common Stock

Stephen Gordon

Chief Financial Officer

Andover, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TMDX shares.

Notify only if

Value

Insider Trading

Get notified when an Trans Medics Group, Inc. insider buys or sells TMDX shares.

Notify only if

Operation

Value

Type

News

Receive news related to TransMedics Group, Inc.

Track Activities on TMDX

Account